Discussions Around the DeLLphi-305 Trial
Sevabertinib Moves Into First-Line HER2-Mutant NSCLC With FDA Accelerated Approval
FDA Expands Accelerated Approval of Sevabertinib for HER2-Mutant Non-small Cell Lung Cancer
Hodgkin Lymphoma in 2026: What the New EHA Guidelines Recommend
Vanessa Kerry։ Honored to Have Been Appointed as the Director-General's Special Envoy for Health Resilience
Benjamin L. Ebert: A Major Step Forward for Personalized Cancer Vaccines
Gilberto Lopes: DeLLphi-305 Signals a Potential Shift in First-Line SCLC
MOB-RT Supports Moderate Hypofractionated Pelvic Radiotherapy in High-Risk Prostate Cancer
LeukO 2026: Global Virtual Congress on Leukemias
O Series
Passed
Community Oncology Global Congress 2026
Passed
Yvonne Awards 2026
Yvonne Awards
Passed
How I Treat Bladder Cancer in 2026: OncoDaily Virtual Summit
How I Treat
Passed
How I Treat Head and Neck Cancers in 2026: OncoDaily Virtual Summit
How I Treat
Passed
Changing the Cancer World: An OncoDaily Session at SELAC 2026
Passed
How I Treat Gallbladder and Bile Duct Cancer in 2026: OncoDaily Virtual Summit
How I Treat
